跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DABIGATRAN ETEXILATO ADAMED 150 MG CAPSULAS DURAS - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
DABIGATRAN ETEXILATO ADAMED 150 MG CAPSULAS DURAS
Approved
STANDARD
DABIGATRAN ETEXILATO ADAMED 150 MG CAPSULAS DURAS
Adamed Pharma S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Apr 22, 2024
Approval ID
15e47bc5548077bd
Company
Adamed Pharma S.A.
Type
Standard
Approval Details
Approval Id
15e47bc5548077bd
Drug Cima Aemps Name
DABIGATRAN ETEXILATO ADAMED 150 MG CAPSULAS DURAS
Register Number
89512
Holder Company Name
Adamed Pharma S.A.
Marketing Company Name
Adamed Pharma S.A.
Holder Company Detail Path
/organization/adamed-pharma-s-a
Marketing Company Detail Path
/organization/adamed-pharma-s-a
Authorization Date
2024-04-22
Dosage Form
CÁPSULA DURA
Dose
150 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Adamed Pharma S.A.
Company Detail Path
/organization/adamed-pharma-s-a
Company Information
Pharmaceutical Company Name
Adamed Pharma S.A.
Country Name
Poland
Website
https://www.adamed.com/
Active Ingredients
DABIGATRAN ETEXILATO MESILATO
172,95 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Apr 22, 2024
Approval ID
15e47bc5548077bd
Type
Standard
Back to CIMA-AEMPS Approvals
